VERICI DX PLC
VRCI | IL
Overview
Corporate Details
- ISIN(s):
- GB00BM8HZD43
- LEI:
- 213800FI5WE4FVQ3G645
- Country:
- United Kingdom
- Address:
- AVON HOUSE, CF64 2EZ CARDIFF
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Verici Dx offers AI-driven diagnostic tests using RNA signatures to improve kidney transplant outcomes. We provide next-generation sequencing and multiomics lab services, accelerating innovation through research and collaboration to enhance patient care.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-30 08:00 |
Earnings Release
Final Results
|
English | 695.6 KB | |
| 2025-06-11 08:00 |
Business and Financial Review
Update on funding to accelerate commercial growth
|
English | 12.1 KB | |
| 2025-05-27 15:42 |
Declaration of Voting Results & Voting Rights Announcements
Result of General Meeting
|
English | 15.1 KB | |
| 2025-05-09 17:38 |
Capital/Financing Update
Publication of Circular
|
English | 14.3 KB | |
| 2025-01-14 12:01 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.9 KB | |
| 2024-10-11 08:00 |
Regulatory News Service
Update on Local Coverage Determination and Trading
|
English | 15.4 KB | |
| 2024-07-31 08:00 |
Regulatory News Service
Launch of PTRA Assay using Verici Dx's technology
|
English | 15.1 KB | |
| 2024-07-15 08:00 |
Earnings Release
Half-year Report
|
English | 347.9 KB | |
| 2024-07-11 15:00 |
Earnings Release
Notice of Results and Business Update
|
English | 11.9 KB | |
| 2024-07-01 08:00 |
Regulatory News Service
Significant milestone re Thermo Fisher agreement
|
English | 14.4 KB | |
| 2024-06-25 14:27 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 23.3 KB | |
| 2024-06-18 08:00 |
Regulatory News Service
Transfer of urine samples to Thermo Fisher
|
English | 12.8 KB | |
| 2024-05-31 14:57 |
Proxy Solicitation & Information Statements
Notice of AGM and posting of Annual Report
|
English | 14.3 KB | |
| 2024-05-31 11:00 |
Regulatory News Service
Launch of patient-focused educational tool
|
English | 16.6 KB | |
| 2024-05-30 08:00 |
Earnings Release
2023 Annual Results
|
English | 496.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Deversify Health AB | Sweden | DEV | |
|
Diagonal Bio AB | Sweden | DIABIO | |
| EDX Medical Group Plc | United Kingdom | N/A | ||
|
Elekta | Sweden | EKTA | |
|
Elos Medtech | Sweden | ELOS | |
|
Episurf | Sweden | EPIS | |
|
FluoGuide A/S | Denmark | FLUO | |
|
GELION PLC | United Kingdom | GELN | |
|
Genetic Analysis AS | Norway | GEAN | |
|
Genomed Spolka Akcyjna | Poland | GEN |